Ticker > Company >

Modern Diagnostic share price

Modern Diagnostic & Research Centre Ltd.

BSE: 544673 SECTOR: Hospital & Healthcare Services  207   1   0

89.20
-4.69 (-5.00%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 91.1

Today's Low

₹ 89.2

52 Week High

₹ 100

52 Week Low

₹ 87

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

134.68 Cr.

Enterprise Value

156 Cr.

No. of Shares

1.51 Cr.

P/E

15.02

P/B

2.34

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  38.16

CASH

0.78 Cr.

DEBT

22.09 Cr.

Promoter Holding

72.85 %

EPS (TTM)

₹  5.94

Sales Growth

16.11%

ROE

55.21 %

ROCE

39%

Profit Growth

54.76 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 1Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year16.11%
3 Year8.99%
5 YearNA

Profit Growth

1 Year54.76%
3 Year101.48%
5 YearNA

ROE%

1 Year55.21%
3 Year18.56%

ROCE %

1 Year39%
3 Year18.15%

Debt/Equity

1.066

Price to Cash Flow

9.81

Interest Cover Ratio

7.6691

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2025 72.85 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of -90.5745 days.
  • The company has a high promoter holding of 72.85%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 20.140614717842.

 Limitations

  • The company has shown a poor revenue growth of 8.98852966257888% for the Past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 60.21 56.28 67.13 77.95
Total Expenditure 54.21 57.27 56.08 59.98
Operating Profit 5.99 -0.99 11.05 17.96
Other Income 0.37 0.32 1.54 0.86
Interest 1.57 1.41 1.81 1.91
Depreciation 3.66 3.87 3.92 4.19
Exceptional Items 0 0 0 0
Profit Before Tax 1.14 -5.94 6.86 12.72
Tax 2.59 -0.21 1.07 3.76
Net Profit -1.45 -5.73 5.79 8.97
Adjusted EPS (Rs.) -1.32 -5.21 5.27 8.15

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 1 1 1 11
Total Reserves 10.7 4.96 10.76 9.73
Borrowings 13.24 5.81 10.14 8.3
Other N/C liabilities 3.26 3.58 3.56 3.63
Current liabilities 20.5 21.18 24.03 31.92
Total Liabilities 48.7 36.54 49.49 64.57
Assets
Net Block 24.31 23.67 27.04 30.65
Capital WIP 0.46 0 3.6 8.95
Intangible WIP 0.29 0 0 0
Investments 5.29 0.11 0.21 0.23
Loans & Advances 0.45 0.5 0.58 0.91
Other N/C Assets 0 0 0 0
Current Assets 17.89 12.26 18.05 23.83
Total Assets 48.7 36.54 49.49 64.57
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 1.14 -5.94 6.86 12.72
Adjustment 4.75 5.1 5.75 6.01
Changes in Assets & Liabilities -2.74 0.73 -5.95 -1.21
Tax Paid 0.49 0 1.26 -3.79
Operating Cash Flow 3.64 -0.12 7.93 13.73
Investing Cash Flow -5.2 2.11 -11.03 -13.14
Financing Cash Flow 4.5 -6.47 3.36 -0.22
Net Cash Flow 2.94 -4.48 0.26 0.37

Corporate Actions

Investors Details

PARTICULARS Dec 2025%
promoters 72.85
asha yadav 3.64
deepali yadav 3.64
devendra singh yadav 61.20
nitin kumar 3.64
sunita yadav 0.73
PARTICULARS Dec 2025%
investors 27.15
aarth aif growth fund 1.31
sb opportunities fund ii 1.09
spread x securities priva... 1.37

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Modern Diagnostic Stock Price Analysis and Quick Research Report. Is Modern Diagnostic an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Modern Diagnostic. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Modern Diagnostic has a PE ratio of 15.3127367623537 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Modern Diagnostic has ROA of 15.7252% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Modern Diagnostic has a Current ratio of 0.7467.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Modern Diagnostic has a ROE of 55.2146%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Modern Diagnostic has a Debt to Equity ratio of 1.066 which means that the company has low proportion of debt in its capital.

  • Sales growth: Modern Diagnostic has reported revenue growth of 16.1103% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Modern Diagnostic for the current financial year is 23.0449776381929%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Modern Diagnostic is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Modern Diagnostic is Rs 5.9395. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Modern Diagnostic in Ticker for free. Also, one can get the intrinsic value of Modern Diagnostic by using Valuation Calculators, which are available with a Finology ONE subscription. 

Modern Diagnostic FAQs

Q1. What is Modern Diagnostic share price today?
Ans: The current share price of Modern Diagnostic is Rs 90.95.

Q2. What is the market capitalisation of Modern Diagnostic?
Ans: Modern Diagnostic has a market capitalisation of Rs 137.327224 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Modern Diagnostic?
Ans: The PE ratio of Modern Diagnostic is 15.3127367623537 and the P/B ratio of Modern Diagnostic is 2.3833607614176, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Modern Diagnostic share?
Ans: The 52-week high share price of Modern Diagnostic is Rs 100, and the 52-week low share price of Modern Diagnostic is Rs 87.

Q5. Does Modern Diagnostic pay dividends?
Ans: Currently, Modern Diagnostic does not pay dividends. Dividend yield of Modern Diagnostic is around 0%.

Q6. What are the face value and book value of Modern Diagnostic shares?
Ans: The face value of Modern Diagnostic shares is Rs 10, while the book value per share of Modern Diagnostic is around Rs 38.1604. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Modern Diagnostic?
Ans: Modern Diagnostic has a total debt of Rs 22.0948 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Modern Diagnostic?
Ans: The ROE of Modern Diagnostic is 55.2146% and ROCE of Modern Diagnostic is 38.9992%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Modern Diagnostic a good buy for the long term?
Ans: The Modern Diagnostic long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Modern Diagnostic undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Modern Diagnostic appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Modern Diagnostic’s financials?
Ans: You can review Modern Diagnostic’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Modern Diagnostic
X